BELGRADE, Mont., Dec. 08, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, has received a CE (Conformité Européenne) Mark for the Certex® OCT Spinal Fixation System and is initiating a worldwide launch of the system.
The Certex® OCT Spinal Fixation System complements and completes the CertexTM Cervico-Thoracic Spinal Fixation System. The Certex® System is intended to promote fusion of the occipito-cervico-thoracic regions of the spine (Occiput-T3 inclusive).
“The Certex® OCT was developed with a panel of designing surgeons to address market and patient needs worldwide. It is Xtant Medical’s mission to lead through innovative design with surgeon practicality” stated Greg Causey, Ph.D, Vice President of Engineering at Xtant Medical.
According to the 2015 iData report, the total addressable US market for posterior cervical fixation with an occipitocervical plate is $299M and growing.
About Xtant Medical Holdings
Xtant Medical Holdings, Inc. (NYSE:XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.
